nodes	percent_of_prediction	percent_of_DWPC	metapath
Agomelatine—CYP1A2—Diphenhydramine—atopic dermatitis	0.0838	0.321	CbGbCtD
Agomelatine—CYP2C9—Loratadine—atopic dermatitis	0.0755	0.289	CbGbCtD
Agomelatine—CYP2C9—Diphenhydramine—atopic dermatitis	0.0755	0.289	CbGbCtD
Agomelatine—CYP2C9—Dexamethasone—atopic dermatitis	0.0261	0.1	CbGbCtD
Agomelatine—Indomethacin—PPARA—atopic dermatitis	0.00633	0.591	CrCbGaD
Agomelatine—Indomethacin—CXCL8—atopic dermatitis	0.00439	0.409	CrCbGaD
Agomelatine—Diarrhoea—Pimecrolimus—atopic dermatitis	0.00138	0.00275	CcSEcCtD
Agomelatine—Dizziness—Dimenhydrinate—atopic dermatitis	0.00138	0.00275	CcSEcCtD
Agomelatine—Dizziness—Diphenhydramine—atopic dermatitis	0.00138	0.00275	CcSEcCtD
Agomelatine—Constipation—Loratadine—atopic dermatitis	0.00138	0.00273	CcSEcCtD
Agomelatine—Infection—Mometasone—atopic dermatitis	0.00137	0.00273	CcSEcCtD
Agomelatine—Mental disorder—Tacrolimus—atopic dermatitis	0.00135	0.00269	CcSEcCtD
Agomelatine—Irritability—Hydrocortisone—atopic dermatitis	0.00133	0.00265	CcSEcCtD
Agomelatine—Vomiting—Dimenhydrinate—atopic dermatitis	0.00133	0.00264	CcSEcCtD
Agomelatine—Vomiting—Diphenhydramine—atopic dermatitis	0.00133	0.00264	CcSEcCtD
Agomelatine—Gastrointestinal pain—Loratadine—atopic dermatitis	0.00132	0.00262	CcSEcCtD
Agomelatine—Headache—Diphenhydramine—atopic dermatitis	0.00131	0.0026	CcSEcCtD
Agomelatine—Headache—Dimenhydrinate—atopic dermatitis	0.00131	0.0026	CcSEcCtD
Agomelatine—Back pain—Tacrolimus—atopic dermatitis	0.0013	0.00259	CcSEcCtD
Agomelatine—Vomiting—Pimecrolimus—atopic dermatitis	0.00128	0.00255	CcSEcCtD
Agomelatine—Abdominal pain—Loratadine—atopic dermatitis	0.00127	0.00253	CcSEcCtD
Agomelatine—Vision blurred—Tacrolimus—atopic dermatitis	0.00127	0.00252	CcSEcCtD
Agomelatine—Headache—Pimecrolimus—atopic dermatitis	0.00126	0.00252	CcSEcCtD
Agomelatine—Tremor—Tacrolimus—atopic dermatitis	0.00126	0.00251	CcSEcCtD
Agomelatine—Irritability—Methylprednisolone—atopic dermatitis	0.00125	0.00249	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Fluocinolone Acetonide—atopic dermatitis	0.00125	0.00248	CcSEcCtD
Agomelatine—Nausea—Dimenhydrinate—atopic dermatitis	0.00124	0.00247	CcSEcCtD
Agomelatine—Nausea—Diphenhydramine—atopic dermatitis	0.00124	0.00247	CcSEcCtD
Agomelatine—Paraesthesia—Mometasone—atopic dermatitis	0.00124	0.00246	CcSEcCtD
Agomelatine—Agitation—Tacrolimus—atopic dermatitis	0.00124	0.00246	CcSEcCtD
Agomelatine—Dyspepsia—Mometasone—atopic dermatitis	0.00121	0.00242	CcSEcCtD
Agomelatine—Vertigo—Tacrolimus—atopic dermatitis	0.00121	0.0024	CcSEcCtD
Agomelatine—Nausea—Pimecrolimus—atopic dermatitis	0.0012	0.00239	CcSEcCtD
Agomelatine—Fatigue—Mometasone—atopic dermatitis	0.00119	0.00237	CcSEcCtD
Agomelatine—Migraine—Dexamethasone—atopic dermatitis	0.00117	0.00233	CcSEcCtD
Agomelatine—Migraine—Betamethasone—atopic dermatitis	0.00117	0.00233	CcSEcCtD
Agomelatine—Asthenia—Loratadine—atopic dermatitis	0.00115	0.00229	CcSEcCtD
Agomelatine—Anxiety—Tacrolimus—atopic dermatitis	0.00114	0.00227	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Tacrolimus—atopic dermatitis	0.00114	0.00226	CcSEcCtD
Agomelatine—Irritability—Betamethasone—atopic dermatitis	0.00114	0.00226	CcSEcCtD
Agomelatine—Irritability—Dexamethasone—atopic dermatitis	0.00114	0.00226	CcSEcCtD
Agomelatine—Influenza—Triamcinolone—atopic dermatitis	0.00113	0.00226	CcSEcCtD
Agomelatine—Gastrointestinal pain—Mometasone—atopic dermatitis	0.00113	0.00224	CcSEcCtD
Agomelatine—Weight increased—Prednisolone—atopic dermatitis	0.00112	0.00223	CcSEcCtD
Agomelatine—Dry mouth—Tacrolimus—atopic dermatitis	0.00112	0.00223	CcSEcCtD
Agomelatine—Diarrhoea—Loratadine—atopic dermatitis	0.0011	0.00219	CcSEcCtD
Agomelatine—Weight increased—Hydrocortisone—atopic dermatitis	0.0011	0.00218	CcSEcCtD
Agomelatine—Infection—Tacrolimus—atopic dermatitis	0.00109	0.00217	CcSEcCtD
Agomelatine—Abdominal pain—Mometasone—atopic dermatitis	0.00109	0.00217	CcSEcCtD
Agomelatine—Weight decreased—Hydrocortisone—atopic dermatitis	0.00109	0.00217	CcSEcCtD
Agomelatine—Nervous system disorder—Tacrolimus—atopic dermatitis	0.00108	0.00214	CcSEcCtD
Agomelatine—Infestation NOS—Hydrocortisone—atopic dermatitis	0.00107	0.00214	CcSEcCtD
Agomelatine—Infestation—Hydrocortisone—atopic dermatitis	0.00107	0.00214	CcSEcCtD
Agomelatine—Skin disorder—Tacrolimus—atopic dermatitis	0.00107	0.00212	CcSEcCtD
Agomelatine—Dizziness—Loratadine—atopic dermatitis	0.00106	0.00211	CcSEcCtD
Agomelatine—Hyperhidrosis—Tacrolimus—atopic dermatitis	0.00106	0.00211	CcSEcCtD
Agomelatine—Weight increased—Triamcinolone—atopic dermatitis	0.00103	0.00205	CcSEcCtD
Agomelatine—Weight increased—Methylprednisolone—atopic dermatitis	0.00103	0.00205	CcSEcCtD
Agomelatine—Pruritus—Fluocinolone Acetonide—atopic dermatitis	0.00102	0.00203	CcSEcCtD
Agomelatine—Vomiting—Loratadine—atopic dermatitis	0.00102	0.00203	CcSEcCtD
Agomelatine—Infestation NOS—Methylprednisolone—atopic dermatitis	0.00101	0.00201	CcSEcCtD
Agomelatine—Infestation—Methylprednisolone—atopic dermatitis	0.00101	0.00201	CcSEcCtD
Agomelatine—Headache—Loratadine—atopic dermatitis	0.00101	0.002	CcSEcCtD
Agomelatine—Face oedema—Prednisone—atopic dermatitis	0.001	0.00199	CcSEcCtD
Agomelatine—Insomnia—Tacrolimus—atopic dermatitis	0.000994	0.00198	CcSEcCtD
Agomelatine—Asthenia—Mometasone—atopic dermatitis	0.00099	0.00197	CcSEcCtD
Agomelatine—Irritability—Prednisone—atopic dermatitis	0.00099	0.00197	CcSEcCtD
Agomelatine—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.000989	0.00197	CcSEcCtD
Agomelatine—Paraesthesia—Tacrolimus—atopic dermatitis	0.000986	0.00196	CcSEcCtD
Agomelatine—Somnolence—Tacrolimus—atopic dermatitis	0.000977	0.00194	CcSEcCtD
Agomelatine—Pruritus—Mometasone—atopic dermatitis	0.000976	0.00194	CcSEcCtD
Agomelatine—Dyspepsia—Tacrolimus—atopic dermatitis	0.000967	0.00192	CcSEcCtD
Agomelatine—Hallucination—Hydrocortisone—atopic dermatitis	0.00096	0.00191	CcSEcCtD
Agomelatine—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.000956	0.0019	CcSEcCtD
Agomelatine—Nausea—Loratadine—atopic dermatitis	0.000955	0.0019	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	0.000948	0.00189	CcSEcCtD
Agomelatine—Connective tissue disorder—Hydrocortisone—atopic dermatitis	0.000948	0.00188	CcSEcCtD
Agomelatine—Fatigue—Tacrolimus—atopic dermatitis	0.000947	0.00188	CcSEcCtD
Agomelatine—Diarrhoea—Mometasone—atopic dermatitis	0.000944	0.00188	CcSEcCtD
Agomelatine—Constipation—Tacrolimus—atopic dermatitis	0.000939	0.00187	CcSEcCtD
Agomelatine—Weight increased—Betamethasone—atopic dermatitis	0.000937	0.00186	CcSEcCtD
Agomelatine—Weight increased—Dexamethasone—atopic dermatitis	0.000937	0.00186	CcSEcCtD
Agomelatine—Weight decreased—Dexamethasone—atopic dermatitis	0.000931	0.00185	CcSEcCtD
Agomelatine—Weight decreased—Betamethasone—atopic dermatitis	0.000931	0.00185	CcSEcCtD
Agomelatine—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000919	0.00183	CcSEcCtD
Agomelatine—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000906	0.0018	CcSEcCtD
Agomelatine—Hallucination—Methylprednisolone—atopic dermatitis	0.000902	0.00179	CcSEcCtD
Agomelatine—Eye disorder—Hydrocortisone—atopic dermatitis	0.000901	0.00179	CcSEcCtD
Agomelatine—Gastrointestinal pain—Tacrolimus—atopic dermatitis	0.000898	0.00179	CcSEcCtD
Agomelatine—Connective tissue disorder—Methylprednisolone—atopic dermatitis	0.000891	0.00177	CcSEcCtD
Agomelatine—Vomiting—Mometasone—atopic dermatitis	0.000878	0.00175	CcSEcCtD
Agomelatine—Urticaria—Tacrolimus—atopic dermatitis	0.000873	0.00174	CcSEcCtD
Agomelatine—Abdominal pain—Tacrolimus—atopic dermatitis	0.000868	0.00173	CcSEcCtD
Agomelatine—Headache—Mometasone—atopic dermatitis	0.000865	0.00172	CcSEcCtD
Agomelatine—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000859	0.00171	CcSEcCtD
Agomelatine—Eye disorder—Methylprednisolone—atopic dermatitis	0.000847	0.00168	CcSEcCtD
Agomelatine—Mental disorder—Hydrocortisone—atopic dermatitis	0.000845	0.00168	CcSEcCtD
Agomelatine—Hallucination—Betamethasone—atopic dermatitis	0.00082	0.00163	CcSEcCtD
Agomelatine—Hallucination—Dexamethasone—atopic dermatitis	0.00082	0.00163	CcSEcCtD
Agomelatine—Nausea—Mometasone—atopic dermatitis	0.00082	0.00163	CcSEcCtD
Agomelatine—Weight increased—Prednisone—atopic dermatitis	0.000816	0.00162	CcSEcCtD
Agomelatine—Weight decreased—Prednisone—atopic dermatitis	0.000811	0.00161	CcSEcCtD
Agomelatine—Vision blurred—Prednisolone—atopic dermatitis	0.00081	0.00161	CcSEcCtD
Agomelatine—Depression—Prednisone—atopic dermatitis	0.000797	0.00159	CcSEcCtD
Agomelatine—Mental disorder—Methylprednisolone—atopic dermatitis	0.000794	0.00158	CcSEcCtD
Agomelatine—Asthenia—Tacrolimus—atopic dermatitis	0.000788	0.00157	CcSEcCtD
Agomelatine—Angioedema—Prednisolone—atopic dermatitis	0.000786	0.00156	CcSEcCtD
Agomelatine—Pruritus—Tacrolimus—atopic dermatitis	0.000777	0.00155	CcSEcCtD
Agomelatine—Vertigo—Prednisolone—atopic dermatitis	0.000772	0.00154	CcSEcCtD
Agomelatine—Eye disorder—Dexamethasone—atopic dermatitis	0.00077	0.00153	CcSEcCtD
Agomelatine—Eye disorder—Betamethasone—atopic dermatitis	0.00077	0.00153	CcSEcCtD
Agomelatine—Angioedema—Hydrocortisone—atopic dermatitis	0.000767	0.00153	CcSEcCtD
Agomelatine—Back pain—Triamcinolone—atopic dermatitis	0.000765	0.00152	CcSEcCtD
Agomelatine—Vertigo—Hydrocortisone—atopic dermatitis	0.000754	0.0015	CcSEcCtD
Agomelatine—Diarrhoea—Tacrolimus—atopic dermatitis	0.000752	0.00149	CcSEcCtD
Agomelatine—Dizziness—Tacrolimus—atopic dermatitis	0.000726	0.00144	CcSEcCtD
Agomelatine—Angioedema—Triamcinolone—atopic dermatitis	0.000722	0.00144	CcSEcCtD
Agomelatine—Angioedema—Methylprednisolone—atopic dermatitis	0.000721	0.00143	CcSEcCtD
Agomelatine—Hallucination—Prednisone—atopic dermatitis	0.000714	0.00142	CcSEcCtD
Agomelatine—Anxiety—Hydrocortisone—atopic dermatitis	0.000712	0.00142	CcSEcCtD
Agomelatine—Vertigo—Triamcinolone—atopic dermatitis	0.00071	0.00141	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.00071	0.00141	CcSEcCtD
Agomelatine—Vertigo—Methylprednisolone—atopic dermatitis	0.000709	0.00141	CcSEcCtD
Agomelatine—Connective tissue disorder—Prednisone—atopic dermatitis	0.000705	0.0014	CcSEcCtD
Agomelatine—Vomiting—Tacrolimus—atopic dermatitis	0.000698	0.00139	CcSEcCtD
Agomelatine—Headache—Tacrolimus—atopic dermatitis	0.000688	0.00137	CcSEcCtD
Agomelatine—Infection—Hydrocortisone—atopic dermatitis	0.000681	0.00135	CcSEcCtD
Agomelatine—Hyperhidrosis—Prednisolone—atopic dermatitis	0.000678	0.00135	CcSEcCtD
Agomelatine—MTNR1B—Signaling Pathways—CCL27—atopic dermatitis	0.000672	0.00298	CbGpPWpGaD
Agomelatine—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000672	0.00134	CcSEcCtD
Agomelatine—Eye disorder—Prednisone—atopic dermatitis	0.000671	0.00133	CcSEcCtD
Agomelatine—MTNR1B—Signaling by GPCR—CCR3—atopic dermatitis	0.000671	0.00297	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—CCR3—atopic dermatitis	0.000671	0.00297	CbGpPWpGaD
Agomelatine—Anxiety—Methylprednisolone—atopic dermatitis	0.000669	0.00133	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.000667	0.00133	CcSEcCtD
Agomelatine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—atopic dermatitis	0.000667	0.00295	CbGpPWpGaD
Agomelatine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—atopic dermatitis	0.000667	0.00295	CbGpPWpGaD
Agomelatine—Skin disorder—Hydrocortisone—atopic dermatitis	0.000666	0.00132	CcSEcCtD
Agomelatine—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000662	0.00132	CcSEcCtD
Agomelatine—Dry mouth—Triamcinolone—atopic dermatitis	0.000658	0.00131	CcSEcCtD
Agomelatine—MTNR1A—GPCR downstream signaling—NPS—atopic dermatitis	0.000658	0.00292	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—TAC1—atopic dermatitis	0.000658	0.00292	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—TAC1—atopic dermatitis	0.000658	0.00292	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—NPS—atopic dermatitis	0.000658	0.00292	CbGpPWpGaD
Agomelatine—Angioedema—Betamethasone—atopic dermatitis	0.000655	0.0013	CcSEcCtD
Agomelatine—Angioedema—Dexamethasone—atopic dermatitis	0.000655	0.0013	CcSEcCtD
Agomelatine—Nausea—Tacrolimus—atopic dermatitis	0.000652	0.0013	CcSEcCtD
Agomelatine—HTR2C—GPCR ligand binding—CCL22—atopic dermatitis	0.000648	0.00287	CbGpPWpGaD
Agomelatine—HTR2B—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.000646	0.00287	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000645	0.00286	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000645	0.00286	CbGpPWpGaD
Agomelatine—Vertigo—Dexamethasone—atopic dermatitis	0.000645	0.00128	CcSEcCtD
Agomelatine—Vertigo—Betamethasone—atopic dermatitis	0.000645	0.00128	CcSEcCtD
Agomelatine—HTR2B—GPCR ligand binding—CCL17—atopic dermatitis	0.000642	0.00284	CbGpPWpGaD
Agomelatine—Infection—Triamcinolone—atopic dermatitis	0.000641	0.00127	CcSEcCtD
Agomelatine—Infection—Methylprednisolone—atopic dermatitis	0.00064	0.00127	CcSEcCtD
Agomelatine—Insomnia—Prednisolone—atopic dermatitis	0.000635	0.00126	CcSEcCtD
Agomelatine—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000631	0.00126	CcSEcCtD
Agomelatine—Paraesthesia—Prednisolone—atopic dermatitis	0.00063	0.00125	CcSEcCtD
Agomelatine—Mental disorder—Prednisone—atopic dermatitis	0.000629	0.00125	CcSEcCtD
Agomelatine—Skin disorder—Methylprednisolone—atopic dermatitis	0.000625	0.00124	CcSEcCtD
Agomelatine—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000624	0.00124	CcSEcCtD
Agomelatine—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000622	0.00124	CcSEcCtD
Agomelatine—Insomnia—Hydrocortisone—atopic dermatitis	0.00062	0.00123	CcSEcCtD
Agomelatine—Paraesthesia—Hydrocortisone—atopic dermatitis	0.000615	0.00122	CcSEcCtD
Agomelatine—MTNR1A—GPCR downstream signaling—IL5—atopic dermatitis	0.000612	0.00271	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—IL5—atopic dermatitis	0.000612	0.00271	CbGpPWpGaD
Agomelatine—Anxiety—Betamethasone—atopic dermatitis	0.000609	0.00121	CcSEcCtD
Agomelatine—Anxiety—Dexamethasone—atopic dermatitis	0.000609	0.00121	CcSEcCtD
Agomelatine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.000605	0.00268	CbGpPWpGaD
Agomelatine—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000603	0.0012	CcSEcCtD
Agomelatine—MTNR1A—Signaling Pathways—CCL17—atopic dermatitis	0.000603	0.00267	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—CCL17—atopic dermatitis	0.000603	0.00267	CbGpPWpGaD
Agomelatine—HTR2C—G alpha (q) signalling events—TAC1—atopic dermatitis	0.000601	0.00267	CbGpPWpGaD
Agomelatine—HTR2C—G alpha (q) signalling events—NPS—atopic dermatitis	0.000601	0.00267	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—TAC1—atopic dermatitis	0.000598	0.00265	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—NPS—atopic dermatitis	0.000598	0.00265	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—NPS—atopic dermatitis	0.000598	0.00265	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—TAC1—atopic dermatitis	0.000598	0.00265	CbGpPWpGaD
Agomelatine—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000592	0.00118	CcSEcCtD
Agomelatine—Fatigue—Hydrocortisone—atopic dermatitis	0.000591	0.00117	CcSEcCtD
Agomelatine—Vision blurred—Prednisone—atopic dermatitis	0.000589	0.00117	CcSEcCtD
Agomelatine—MTNR1B—Signaling by GPCR—CXCR3—atopic dermatitis	0.000586	0.0026	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—CXCR3—atopic dermatitis	0.000586	0.0026	CbGpPWpGaD
Agomelatine—Insomnia—Triamcinolone—atopic dermatitis	0.000584	0.00116	CcSEcCtD
Agomelatine—Insomnia—Methylprednisolone—atopic dermatitis	0.000582	0.00116	CcSEcCtD
Agomelatine—Infection—Betamethasone—atopic dermatitis	0.000582	0.00116	CcSEcCtD
Agomelatine—Infection—Dexamethasone—atopic dermatitis	0.000582	0.00116	CcSEcCtD
Agomelatine—Paraesthesia—Triamcinolone—atopic dermatitis	0.000579	0.00115	CcSEcCtD
Agomelatine—Paraesthesia—Methylprednisolone—atopic dermatitis	0.000578	0.00115	CcSEcCtD
Agomelatine—HTR2C—GPCR ligand binding—CCL27—atopic dermatitis	0.000577	0.00256	CbGpPWpGaD
Agomelatine—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000574	0.00114	CcSEcCtD
Agomelatine—Nervous system disorder—Betamethasone—atopic dermatitis	0.000574	0.00114	CcSEcCtD
Agomelatine—Agitation—Prednisone—atopic dermatitis	0.000574	0.00114	CcSEcCtD
Agomelatine—Angioedema—Prednisone—atopic dermatitis	0.000571	0.00114	CcSEcCtD
Agomelatine—MTNR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000568	0.00252	CbGpPWpGaD
Agomelatine—MTNR1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000568	0.00252	CbGpPWpGaD
Agomelatine—Dyspepsia—Triamcinolone—atopic dermatitis	0.000568	0.00113	CcSEcCtD
Agomelatine—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000567	0.00113	CcSEcCtD
Agomelatine—Hyperhidrosis—Betamethasone—atopic dermatitis	0.000566	0.00113	CcSEcCtD
Agomelatine—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.000566	0.00113	CcSEcCtD
Agomelatine—HTR2B—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.000565	0.0025	CbGpPWpGaD
Agomelatine—Vertigo—Prednisone—atopic dermatitis	0.000561	0.00112	CcSEcCtD
Agomelatine—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.00056	0.00111	CcSEcCtD
Agomelatine—Urticaria—Prednisolone—atopic dermatitis	0.000557	0.00111	CcSEcCtD
Agomelatine—Fatigue—Triamcinolone—atopic dermatitis	0.000556	0.00111	CcSEcCtD
Agomelatine—MTNR1A—Signaling by GPCR—IL5—atopic dermatitis	0.000556	0.00246	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—IL5—atopic dermatitis	0.000556	0.00246	CbGpPWpGaD
Agomelatine—Fatigue—Methylprednisolone—atopic dermatitis	0.000555	0.0011	CcSEcCtD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.000554	0.00245	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.000548	0.00243	CbGpPWpGaD
Agomelatine—Urticaria—Hydrocortisone—atopic dermatitis	0.000544	0.00108	CcSEcCtD
Agomelatine—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000542	0.00108	CcSEcCtD
Agomelatine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—atopic dermatitis	0.000538	0.00238	CbGpPWpGaD
Agomelatine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—atopic dermatitis	0.000538	0.00238	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—KIF3A—atopic dermatitis	0.000537	0.00238	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—KIF3A—atopic dermatitis	0.000537	0.00238	CbGpPWpGaD
Agomelatine—Anxiety—Prednisone—atopic dermatitis	0.00053	0.00105	CcSEcCtD
Agomelatine—Insomnia—Betamethasone—atopic dermatitis	0.00053	0.00105	CcSEcCtD
Agomelatine—Insomnia—Dexamethasone—atopic dermatitis	0.00053	0.00105	CcSEcCtD
Agomelatine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.000528	0.00105	CcSEcCtD
Agomelatine—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000526	0.00105	CcSEcCtD
Agomelatine—Paraesthesia—Dexamethasone—atopic dermatitis	0.000526	0.00105	CcSEcCtD
Agomelatine—Paraesthesia—Betamethasone—atopic dermatitis	0.000526	0.00105	CcSEcCtD
Agomelatine—MTNR1A—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000522	0.00231	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000522	0.00231	CbGpPWpGaD
Agomelatine—HTR2C—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.000522	0.00231	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—CCL17—atopic dermatitis	0.000518	0.0023	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—CCL11—atopic dermatitis	0.000517	0.00229	CbGpPWpGaD
Agomelatine—Dyspepsia—Betamethasone—atopic dermatitis	0.000515	0.00102	CcSEcCtD
Agomelatine—Dyspepsia—Dexamethasone—atopic dermatitis	0.000515	0.00102	CcSEcCtD
Agomelatine—Urticaria—Triamcinolone—atopic dermatitis	0.000513	0.00102	CcSEcCtD
Agomelatine—Urticaria—Methylprednisolone—atopic dermatitis	0.000511	0.00102	CcSEcCtD
Agomelatine—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000509	0.00101	CcSEcCtD
Agomelatine—Infection—Prednisone—atopic dermatitis	0.000507	0.00101	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000505	0.00101	CcSEcCtD
Agomelatine—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000505	0.00101	CcSEcCtD
Agomelatine—Fatigue—Betamethasone—atopic dermatitis	0.000505	0.001	CcSEcCtD
Agomelatine—Fatigue—Dexamethasone—atopic dermatitis	0.000505	0.001	CcSEcCtD
Agomelatine—Nervous system disorder—Prednisone—atopic dermatitis	0.0005	0.000994	CcSEcCtD
Agomelatine—Skin disorder—Prednisone—atopic dermatitis	0.000495	0.000985	CcSEcCtD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000494	0.00219	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000494	0.00219	CbGpPWpGaD
Agomelatine—Hyperhidrosis—Prednisone—atopic dermatitis	0.000493	0.00098	CcSEcCtD
Agomelatine—Asthenia—Hydrocortisone—atopic dermatitis	0.000492	0.000978	CcSEcCtD
Agomelatine—MTNR1B—Signaling Pathways—CCL11—atopic dermatitis	0.000486	0.00215	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—CCL11—atopic dermatitis	0.000486	0.00215	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—CMA1—atopic dermatitis	0.000486	0.00215	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—CMA1—atopic dermatitis	0.000486	0.00215	CbGpPWpGaD
Agomelatine—Pruritus—Hydrocortisone—atopic dermatitis	0.000485	0.000964	CcSEcCtD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000484	0.00215	CbGpPWpGaD
Agomelatine—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000479	0.000952	CcSEcCtD
Agomelatine—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000479	0.000952	CcSEcCtD
Agomelatine—MTNR1B—Signaling by GPCR—CXCL10—atopic dermatitis	0.000474	0.0021	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—CXCL10—atopic dermatitis	0.000474	0.0021	CbGpPWpGaD
Agomelatine—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000469	0.000932	CcSEcCtD
Agomelatine—Urticaria—Dexamethasone—atopic dermatitis	0.000465	0.000925	CcSEcCtD
Agomelatine—Urticaria—Betamethasone—atopic dermatitis	0.000465	0.000925	CcSEcCtD
Agomelatine—Dizziness—Prednisolone—atopic dermatitis	0.000464	0.000923	CcSEcCtD
Agomelatine—Asthenia—Triamcinolone—atopic dermatitis	0.000463	0.000921	CcSEcCtD
Agomelatine—Abdominal pain—Dexamethasone—atopic dermatitis	0.000463	0.00092	CcSEcCtD
Agomelatine—Abdominal pain—Betamethasone—atopic dermatitis	0.000463	0.00092	CcSEcCtD
Agomelatine—Asthenia—Methylprednisolone—atopic dermatitis	0.000462	0.000919	CcSEcCtD
Agomelatine—Insomnia—Prednisone—atopic dermatitis	0.000461	0.000917	CcSEcCtD
Agomelatine—Paraesthesia—Prednisone—atopic dermatitis	0.000458	0.00091	CcSEcCtD
Agomelatine—MTNR1A—Signaling Pathways—STAT6—atopic dermatitis	0.000457	0.00202	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—STAT6—atopic dermatitis	0.000457	0.00202	CbGpPWpGaD
Agomelatine—Pruritus—Triamcinolone—atopic dermatitis	0.000457	0.000908	CcSEcCtD
Agomelatine—HTR2C—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.000456	0.00202	CbGpPWpGaD
Agomelatine—Pruritus—Methylprednisolone—atopic dermatitis	0.000455	0.000906	CcSEcCtD
Agomelatine—MTNR1B—Circadian rythm related genes—IL6—atopic dermatitis	0.000455	0.00202	CbGpPWpGaD
Agomelatine—MTNR1A—Circadian rythm related genes—IL6—atopic dermatitis	0.000455	0.00202	CbGpPWpGaD
Agomelatine—Dizziness—Hydrocortisone—atopic dermatitis	0.000453	0.000901	CcSEcCtD
Agomelatine—MTNR1B—GPCR downstream signaling—CCL5—atopic dermatitis	0.000449	0.00199	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—CCL5—atopic dermatitis	0.000449	0.00199	CbGpPWpGaD
Agomelatine—Dyspepsia—Prednisone—atopic dermatitis	0.000449	0.000893	CcSEcCtD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.000447	0.00198	CbGpPWpGaD
Agomelatine—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000441	0.000876	CcSEcCtD
Agomelatine—Fatigue—Prednisone—atopic dermatitis	0.00044	0.000874	CcSEcCtD
Agomelatine—Headache—Prednisolone—atopic dermatitis	0.00044	0.000874	CcSEcCtD
Agomelatine—Constipation—Prednisone—atopic dermatitis	0.000436	0.000867	CcSEcCtD
Agomelatine—Vomiting—Hydrocortisone—atopic dermatitis	0.000436	0.000866	CcSEcCtD
Agomelatine—MTNR1A—GPCR ligand binding—CXCL8—atopic dermatitis	0.000433	0.00192	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR ligand binding—CXCL8—atopic dermatitis	0.000433	0.00192	CbGpPWpGaD
Agomelatine—Headache—Hydrocortisone—atopic dermatitis	0.000429	0.000854	CcSEcCtD
Agomelatine—Dizziness—Triamcinolone—atopic dermatitis	0.000427	0.000849	CcSEcCtD
Agomelatine—Dizziness—Methylprednisolone—atopic dermatitis	0.000426	0.000847	CcSEcCtD
Agomelatine—HTR2B—GPCR ligand binding—CCR3—atopic dermatitis	0.000422	0.00187	CbGpPWpGaD
Agomelatine—Asthenia—Dexamethasone—atopic dermatitis	0.00042	0.000835	CcSEcCtD
Agomelatine—Asthenia—Betamethasone—atopic dermatitis	0.00042	0.000835	CcSEcCtD
Agomelatine—HTR2C—GPCR ligand binding—CCL11—atopic dermatitis	0.000417	0.00185	CbGpPWpGaD
Agomelatine—Gastrointestinal pain—Prednisone—atopic dermatitis	0.000417	0.000829	CcSEcCtD
Agomelatine—Nausea—Prednisolone—atopic dermatitis	0.000417	0.000829	CcSEcCtD
Agomelatine—Pruritus—Betamethasone—atopic dermatitis	0.000414	0.000824	CcSEcCtD
Agomelatine—Pruritus—Dexamethasone—atopic dermatitis	0.000414	0.000824	CcSEcCtD
Agomelatine—HTR2B—Signaling by GPCR—CCL22—atopic dermatitis	0.000412	0.00183	CbGpPWpGaD
Agomelatine—Vomiting—Triamcinolone—atopic dermatitis	0.00041	0.000816	CcSEcCtD
Agomelatine—Vomiting—Methylprednisolone—atopic dermatitis	0.000409	0.000814	CcSEcCtD
Agomelatine—MTNR1A—Signaling by GPCR—CCL5—atopic dermatitis	0.000408	0.00181	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—CCL5—atopic dermatitis	0.000408	0.00181	CbGpPWpGaD
Agomelatine—Nausea—Hydrocortisone—atopic dermatitis	0.000407	0.000809	CcSEcCtD
Agomelatine—Urticaria—Prednisone—atopic dermatitis	0.000405	0.000805	CcSEcCtD
Agomelatine—MTNR1B—GPCR downstream signaling—CCR5—atopic dermatitis	0.000405	0.00179	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—CCR5—atopic dermatitis	0.000405	0.00179	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—CCL27—atopic dermatitis	0.000404	0.00179	CbGpPWpGaD
Agomelatine—Headache—Triamcinolone—atopic dermatitis	0.000404	0.000804	CcSEcCtD
Agomelatine—Headache—Methylprednisolone—atopic dermatitis	0.000403	0.000802	CcSEcCtD
Agomelatine—Abdominal pain—Prednisone—atopic dermatitis	0.000403	0.000802	CcSEcCtD
Agomelatine—Diarrhoea—Dexamethasone—atopic dermatitis	0.000401	0.000797	CcSEcCtD
Agomelatine—Diarrhoea—Betamethasone—atopic dermatitis	0.000401	0.000797	CcSEcCtD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000398	0.00177	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000398	0.00177	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—CCR3—atopic dermatitis	0.000396	0.00176	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—CCR3—atopic dermatitis	0.000396	0.00176	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000391	0.00173	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000391	0.00173	CbGpPWpGaD
Agomelatine—Dizziness—Betamethasone—atopic dermatitis	0.000387	0.00077	CcSEcCtD
Agomelatine—Dizziness—Dexamethasone—atopic dermatitis	0.000387	0.00077	CcSEcCtD
Agomelatine—Nausea—Triamcinolone—atopic dermatitis	0.000383	0.000762	CcSEcCtD
Agomelatine—Nausea—Methylprednisolone—atopic dermatitis	0.000382	0.00076	CcSEcCtD
Agomelatine—HTR2B—GPCR ligand binding—TAC1—atopic dermatitis	0.000376	0.00167	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—NPS—atopic dermatitis	0.000376	0.00167	CbGpPWpGaD
Agomelatine—Vomiting—Dexamethasone—atopic dermatitis	0.000372	0.00074	CcSEcCtD
Agomelatine—Vomiting—Betamethasone—atopic dermatitis	0.000372	0.00074	CcSEcCtD
Agomelatine—HTR2B—GPCR ligand binding—CXCR3—atopic dermatitis	0.000369	0.00163	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—CCR5—atopic dermatitis	0.000367	0.00163	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—CCR5—atopic dermatitis	0.000367	0.00163	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—CCL27—atopic dermatitis	0.000367	0.00163	CbGpPWpGaD
Agomelatine—Headache—Betamethasone—atopic dermatitis	0.000367	0.000729	CcSEcCtD
Agomelatine—Headache—Dexamethasone—atopic dermatitis	0.000367	0.000729	CcSEcCtD
Agomelatine—Asthenia—Prednisone—atopic dermatitis	0.000366	0.000727	CcSEcCtD
Agomelatine—Pruritus—Prednisone—atopic dermatitis	0.000361	0.000717	CcSEcCtD
Agomelatine—HTR2B—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000354	0.00157	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—TAC1—atopic dermatitis	0.000353	0.00156	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—TAC1—atopic dermatitis	0.000353	0.00156	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—NPS—atopic dermatitis	0.000353	0.00156	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—NPS—atopic dermatitis	0.000353	0.00156	CbGpPWpGaD
Agomelatine—Diarrhoea—Prednisone—atopic dermatitis	0.000349	0.000694	CcSEcCtD
Agomelatine—Nausea—Betamethasone—atopic dermatitis	0.000348	0.000692	CcSEcCtD
Agomelatine—Nausea—Dexamethasone—atopic dermatitis	0.000348	0.000692	CcSEcCtD
Agomelatine—MTNR1A—Signaling Pathways—CXCR3—atopic dermatitis	0.000346	0.00153	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—CXCR3—atopic dermatitis	0.000346	0.00153	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—CCR3—atopic dermatitis	0.00034	0.00151	CbGpPWpGaD
Agomelatine—Dizziness—Prednisone—atopic dermatitis	0.000337	0.00067	CcSEcCtD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000337	0.00149	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CCL22—atopic dermatitis	0.000332	0.00147	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—CCL17—atopic dermatitis	0.000329	0.00146	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—IL5—atopic dermatitis	0.000328	0.00145	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—IL5—atopic dermatitis	0.000328	0.00145	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—CCL27—atopic dermatitis	0.000326	0.00145	CbGpPWpGaD
Agomelatine—Vomiting—Prednisone—atopic dermatitis	0.000324	0.000645	CcSEcCtD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—atopic dermatitis	0.000322	0.00143	CbGpPWpGaD
Agomelatine—Headache—Prednisone—atopic dermatitis	0.000319	0.000635	CcSEcCtD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000316	0.0014	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000303	0.00135	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—TAC1—atopic dermatitis	0.000303	0.00134	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—NPS—atopic dermatitis	0.000303	0.00134	CbGpPWpGaD
Agomelatine—Nausea—Prednisone—atopic dermatitis	0.000303	0.000602	CcSEcCtD
Agomelatine—HTR2B—GPCR ligand binding—CXCL10—atopic dermatitis	0.000298	0.00132	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—CXCR3—atopic dermatitis	0.000297	0.00132	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CCL27—atopic dermatitis	0.000296	0.00131	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—atopic dermatitis	0.000287	0.00127	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—atopic dermatitis	0.000286	0.00127	CbGpPWpGaD
Agomelatine—HTR2C—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000286	0.00127	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—CXCL10—atopic dermatitis	0.00028	0.00124	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—CXCL10—atopic dermatitis	0.00028	0.00124	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000272	0.0012	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CCL17—atopic dermatitis	0.000266	0.00118	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—CCL11—atopic dermatitis	0.000266	0.00118	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—FCER2—atopic dermatitis	0.000262	0.00116	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—CCL5—atopic dermatitis	0.000257	0.00114	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000245	0.00109	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000245	0.00108	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000245	0.00108	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CCL22—atopic dermatitis	0.000243	0.00108	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—CCL5—atopic dermatitis	0.000241	0.00107	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—CCL5—atopic dermatitis	0.000241	0.00107	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—CXCL10—atopic dermatitis	0.00024	0.00107	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—CCR3—atopic dermatitis	0.000238	0.00106	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—IL2—atopic dermatitis	0.000234	0.00104	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—IL2—atopic dermatitis	0.000234	0.00104	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—CCR5—atopic dermatitis	0.000231	0.00102	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.000229	0.00101	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—NGF—atopic dermatitis	0.000223	0.000989	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—NGF—atopic dermatitis	0.000223	0.000989	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—CXCL8—atopic dermatitis	0.000222	0.000984	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—CXCL8—atopic dermatitis	0.000222	0.000984	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—CCR5—atopic dermatitis	0.000217	0.000962	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—CCR5—atopic dermatitis	0.000217	0.000962	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CCL27—atopic dermatitis	0.000217	0.000962	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—CCR3—atopic dermatitis	0.000216	0.000959	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CCL11—atopic dermatitis	0.000214	0.000949	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—TAC1—atopic dermatitis	0.000212	0.000942	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—NPS—atopic dermatitis	0.000212	0.000942	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—IL2—atopic dermatitis	0.000212	0.000941	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—IL2—atopic dermatitis	0.000212	0.000941	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—FCER2—atopic dermatitis	0.000211	0.000936	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—atopic dermatitis	0.000208	0.000924	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—atopic dermatitis	0.000208	0.000924	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000208	0.000923	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—CCL5—atopic dermatitis	0.000207	0.000917	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—IL5—atopic dermatitis	0.000198	0.000875	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CCL22—atopic dermatitis	0.000196	0.00087	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.000196	0.000867	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CCL17—atopic dermatitis	0.000195	0.000862	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—TAC1—atopic dermatitis	0.000193	0.000855	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—NPS—atopic dermatitis	0.000193	0.000855	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—CCR3—atopic dermatitis	0.000192	0.000852	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—CXCR3—atopic dermatitis	0.000189	0.000839	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—CCR5—atopic dermatitis	0.000186	0.000826	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—NFKBIA—atopic dermatitis	0.000184	0.000815	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—NFKBIA—atopic dermatitis	0.000184	0.000815	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000183	0.000813	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—IL5—atopic dermatitis	0.000179	0.000795	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CCL27—atopic dermatitis	0.000175	0.000776	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CCR3—atopic dermatitis	0.000175	0.000774	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—KIF3A—atopic dermatitis	0.000173	0.000769	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—NPS—atopic dermatitis	0.000171	0.00076	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—TAC1—atopic dermatitis	0.000171	0.00076	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000168	0.000746	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000168	0.000745	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—IL5—atopic dermatitis	0.000159	0.000706	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CCL17—atopic dermatitis	0.000157	0.000696	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CCL11—atopic dermatitis	0.000157	0.000695	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CMA1—atopic dermatitis	0.000157	0.000695	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—NPS—atopic dermatitis	0.000156	0.00069	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—TAC1—atopic dermatitis	0.000156	0.00069	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—CXCL10—atopic dermatitis	0.000153	0.000678	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CXCR3—atopic dermatitis	0.000153	0.000677	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000148	0.000656	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—STAT6—atopic dermatitis	0.000147	0.000654	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—CCL5—atopic dermatitis	0.000145	0.000643	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—IL5—atopic dermatitis	0.000145	0.000641	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—KIF3A—atopic dermatitis	0.00014	0.00062	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—CXCL8—atopic dermatitis	0.00014	0.000619	CbGpPWpGaD
Agomelatine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	0.000139	0.000617	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000136	0.000602	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—CCL5—atopic dermatitis	0.000132	0.000583	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—CXCL8—atopic dermatitis	0.000131	0.000582	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—CXCL8—atopic dermatitis	0.000131	0.000582	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—CCR5—atopic dermatitis	0.000131	0.000579	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CCR3—atopic dermatitis	0.000128	0.000567	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CMA1—atopic dermatitis	0.000127	0.000561	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CCL11—atopic dermatitis	0.000127	0.000561	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—IL2—atopic dermatitis	0.000125	0.000556	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—IL2—atopic dermatitis	0.000125	0.000556	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—IL6—atopic dermatitis	0.000125	0.000553	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—IL6—atopic dermatitis	0.000125	0.000553	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CXCL10—atopic dermatitis	0.000123	0.000547	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—STAT6—atopic dermatitis	0.000119	0.000527	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—CCR5—atopic dermatitis	0.000119	0.000526	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—CCL5—atopic dermatitis	0.000117	0.000518	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—MAPK8—atopic dermatitis	0.000115	0.000512	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—MAPK8—atopic dermatitis	0.000115	0.000512	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—NPS—atopic dermatitis	0.000114	0.000505	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—TAC1—atopic dermatitis	0.000114	0.000505	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—CXCL8—atopic dermatitis	0.000113	0.0005	CbGpPWpGaD
Agomelatine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	0.000112	0.000498	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CXCR3—atopic dermatitis	0.000112	0.000495	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CCL5—atopic dermatitis	0.000106	0.000471	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IL5—atopic dermatitis	0.000106	0.00047	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—CCR5—atopic dermatitis	0.000105	0.000467	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CCR3—atopic dermatitis	0.000103	0.000457	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—GLB1—atopic dermatitis	0.000102	0.000452	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—ADSL—atopic dermatitis	9.77e-05	0.000433	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CCR5—atopic dermatitis	9.57e-05	0.000424	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—TAC1—atopic dermatitis	9.19e-05	0.000408	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—NPS—atopic dermatitis	9.19e-05	0.000408	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CXCL10—atopic dermatitis	9.03e-05	0.0004	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CXCR3—atopic dermatitis	9.02e-05	0.0004	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—GLB1—atopic dermatitis	8.71e-05	0.000386	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IL5—atopic dermatitis	8.55e-05	0.000379	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—ADSL—atopic dermatitis	8.35e-05	0.00037	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—CXCL8—atopic dermatitis	7.9e-05	0.00035	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CCL5—atopic dermatitis	7.78e-05	0.000345	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—IL2—atopic dermatitis	7.55e-05	0.000334	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	7.43e-05	0.000329	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—IL6—atopic dermatitis	7.37e-05	0.000327	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—IL6—atopic dermatitis	7.37e-05	0.000327	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CXCL10—atopic dermatitis	7.29e-05	0.000323	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—NGF—atopic dermatitis	7.2e-05	0.000319	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—CXCL8—atopic dermatitis	7.17e-05	0.000318	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CCR5—atopic dermatitis	7.01e-05	0.000311	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—IL2—atopic dermatitis	6.85e-05	0.000304	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—CXCL8—atopic dermatitis	6.37e-05	0.000282	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	6.35e-05	0.000281	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CCL5—atopic dermatitis	6.27e-05	0.000278	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—IL2—atopic dermatitis	6.09e-05	0.00027	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—NFKBIA—atopic dermatitis	5.94e-05	0.000263	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—NGF—atopic dermatitis	5.81e-05	0.000258	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CXCL8—atopic dermatitis	5.78e-05	0.000256	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CCR5—atopic dermatitis	5.65e-05	0.000251	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—IL2—atopic dermatitis	5.53e-05	0.000245	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—NFKBIA—atopic dermatitis	4.79e-05	0.000212	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CXCL8—atopic dermatitis	4.24e-05	0.000188	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IL2—atopic dermatitis	4.05e-05	0.000179	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—IL6—atopic dermatitis	4.03e-05	0.000179	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—MAPK8—atopic dermatitis	3.73e-05	0.000165	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CXCL8—atopic dermatitis	3.42e-05	0.000151	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—PPARA—atopic dermatitis	3.31e-05	0.000147	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IL2—atopic dermatitis	3.27e-05	0.000145	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—IL6—atopic dermatitis	3.25e-05	0.000144	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—MAPK8—atopic dermatitis	3.01e-05	0.000133	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—PPARA—atopic dermatitis	2.83e-05	0.000125	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—IL6—atopic dermatitis	2.38e-05	0.000105	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—IL6—atopic dermatitis	1.92e-05	8.51e-05	CbGpPWpGaD
